NCT00645983View on ClinicalTrials.gov

Chamomile Therapy for Generalized Anxiety

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Generalized Anxiety Disorder
Interventions
DIETARY_SUPPLEMENT

Chamomile Extract

220 mg - 1100 mg daily

OTHER

Placebo

1 to 5 capsules daily

Trial Locations (1)

19104-3309

Depression Research Unit, Universityof Pennsylvania School of Medicine, Philadelphia

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Office of Dietary Supplements (ODS)

NIH

lead

University of Pennsylvania

OTHER

NCT00645983 - Chamomile Therapy for Generalized Anxiety | Biotech Hunter | Biotech Hunter